IP50-08: FGFR3 Mutation with CDKN2A Deletion Defines an Aggressive Subtype with Poor Outcomes Across the Grade Spectrum of Non-Muscle Invasive Bladder Cancer (NMIBC)

IP50-08: FGFR3 Mutation with CDKN2A Deletion Defines an Aggressive Subtype with Poor Outcomes Across the Grade Spectrum of Non-Muscle Invasive Bladder Cancer (NMIBC)

Sunday, May 17, 2026 7:00 AM to 9:00 AM · 1 hr. 59 min. (America/New_York)

146A

Abstract

Speakers

Mark Farha

Urology ResidentNew York Presbyterian - Weill Cornell

Sessions

IP50: Bladder Cancer: Non-invasive IV

Sunday, May 17, 2026 7:00 AM to 9:00 AM

Christopher Anderson · Columbia University Medical Center

William Tabayoyong · Department of Urology

Mary Westerman · Department of Urology, University of North Carolina

Log in

See all the content and easy-to-use features by logging in or registering!